About Enable Medicine
Enable Medicine is a Healthcare company based in Menlo Park (United States) founded in 2019 by Aaron and Sunil Bodapati. Drug research and development services are provided to pharmaceutical sector. Enable Medicine has raised $63.62 million across 2 funding rounds from investors including Anthos Capital, General Catalyst and Initialized Capital. The company has 44 employees. Its website enablemedicine.com draws about 29 thousand monthly visits. Enable Medicine offers products and services including Enable Medicine Platform, Biological Atlas, and Actionable Insights Service. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is ENABLE MEDICINE, INC. Its competitors include Seven Bridges Genomics, Ingenuity Systems and Envisagenics; 3 of its 3 listed competitors have raised funding.
Company details
Enable Medicine was established in 2019 and is headquartered in Menlo Park, United States. Drug research and development services are delivered to clients in the pharmaceutical sector. Operations focus on supporting pharmaceutical companies through specialized RD activities. The company is led by co-founders Aaron and Sunil Bodapati. Geographic emphasis remains on the U.S. market, with services tailored to industry needs in drug innovation.
- Headquarters Menlo Park, United States
- Employees 44
- Founders Aaron, Sunil Bodapati
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website enablemedicine.com
- Legal Name Enable Medicine, Inc.
- Total Equity Funding$63.62M (USD)
in 2 rounds
- Latest Funding Round$60M (USD), Series A
Apr 2022
- InvestorsAnthos Capital
& 7 more
- Employee Count44
Products & Services of Enable Medicine
Enable Medicine offers a comprehensive portfolio of products and services, including Enable Medicine Platform, Biological Atlas, and Actionable Insights Service.
Platform integrates biological data for insights in drug discovery and research.
Tool for exploring multimodal data to support therapeutic decision-making.
Service provides AI-driven analysis for patient stratification and target identification.
Funding Insights of Enable Medicine
Enable Medicine has successfully raised a total of $63.62M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $60 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $63.62M
- Total Rounds 2
- Last Round Series A — $60M
- First Round $3.62M
(Aug 2020)
- Investors Count 8
All 2 funding rounds of Enable Medicine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | $60M | Series A | – | Anthos Capital, General Catalyst | |
| Aug 2020 | $3.62M | Series A | – | – | – |
8 investors in total: 6 institutional and 2 angel.
Investors in Enable Medicine
Enable Medicine has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Anthos Capital, General Catalyst and Initialized Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in innovative consumer and technology companies based in Santa Monica. | anthoscapital.com | |||
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | |||
Seed and early-stage technology investments are managed by the firm. | initialized.com | San Francisco, United States | ||
Venture capital firm | breyercapital.com | Menlo Park, United States | ||
Venture capital fund backed by the Christian family office | presight.vc | West Hollywood, United States | ||
| axialvc.com | ||||
VR Vivek Ramaswamy | Indian angel investor, tech entrepreneur, and active startup mentor | unknown_74ca78d573864638a | ||
NK Neil Kumar | Angel investor and entrepreneur, focusing on tech startups in India. | unknown_5765dcc84a67448ea |
Investor details for Enable Medicine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Enable Medicine
15 people are tracked at Enable Medicine (3 in leadership, 12 in team); the tracked headcount is 44.
| Name | Role | Group |
|---|---|---|
Aaron | Co-Founder | Leadership |
Sunil Bodapati | Co-Founder | Leadership |
Kamni Vijay | CEO | Leadership |
Irene Li | Senior Scientist, Scientific Analysis | Team |
Peter Chou | Scientist | Team |
Aaron Mayer | CSO | Team |
Maha Rahim | Scientist | Team |
桢钦 吴 | Scientist | Team |
Michael Wu | Scientist | Team |
Alex Trevino | Scientist | Team |
Alexandro Trevino | Scientist | Team |
Ben Chidester | Scientist | Team |
Matt Bieniosek | Scientist | Team |
Monee McGrady | Scientist | Team |
Honesty Kim | Scientist | Team |
Complete people profiles for Enable Medicine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Enable Medicine
3 dated milestones of Enable Medicine across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Enable Medicine is founded.
- Funding First funding round of $3.6M.
- Funding Latest funding round, Series A, of $60.0M.
Competitors of Enable Medicine
Enable Medicine has 3 listed competitors in our database, 3 of them funded. They include Seven Bridges Genomics, Ingenuity Systems and Envisagenics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| envisagenics.com | 2014 | Long Island, United States | $46.78M | RNA splicing therapeutics are discovered and developed through AI-driven biotechnology. |
Detailed competitors of Enable Medicine
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Enable Medicine
The website of Enable Medicine (enablemedicine.com) receives about 29K visits a month and ranks #1,349,133 among all websites worldwide, #1,749 in Biotechnology and Pharmaceuticals.
- Monthly visits29K
▲ 48.2% vs previous month
- Unique visitors1.8K
per month
- Global rank#1,349,133
among all websites
- Category rank#1,749
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit5.0
- Average visit7 min 58 sec
- DevicesDesktop 94% · Mobile 6%
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Enable Medicine (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Enable Medicine
Complete news archive for Enable Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enable Medicine
Enable Medicine was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Enable Medicine is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Enable Medicine is a funded company, having raised a total of $63.62M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.62M, raised on Aug 2020.
Enable Medicine has 44 employees.
Enable Medicine was established in 2019 and is headquartered in Menlo Park, United States. Drug research and development services are delivered to clients in the pharmaceutical sector. Operations focus on supporting pharmaceutical companies through specialized RD activities. The company is led by co-founders Aaron and Sunil Bodapati. Geographic emphasis remains on the U.S. market, with services tailored to industry needs in drug innovation.
Enable Medicine's top competitors include Ingenuity Systems, Envisagenics and Seven Bridges Genomics.
Enable Medicine offers Enable Medicine Platform, Biological Atlas, and Actionable Insights Service.
Enable Medicine has 8 investors. Key investors include Anthos Capital, General Catalyst, Initialized Capital, Breyer Capital, and Presight Capital.
Enable Medicine operates through Enable Medicine, Inc..